» Articles » PMID: 15107846

Triad3A, an E3 Ubiquitin-protein Ligase Regulating Toll-like Receptors

Overview
Journal Nat Immunol
Date 2004 Apr 27
PMID 15107846
Citations 147
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of Toll-like receptors (TLRs) results in a proinflammatory response needed to combat infection. Thus, limiting TLR signaling is essential for preventing a protective response from causing injury to the host. Here we describe how a RING finger protein, Triad3A, acts as an E3 ubiquitin-protein ligase and enhances ubiquitination and proteolytic degradation of some TLRs. Triad3A overexpression promoted substantial degradation of TLR4 and TLR9 with a concomitant decrease in signaling, but did not affect TLR2 expression or signaling. Conversely, a reduction in endogenous Triad3A by small interfering RNA increased TLR expression and enhanced TLR activation. Thus, ubiquitination by Triad3A represents one pathway by which the intensity and duration of TLR signaling is controlled.

Citing Articles

Toll-like receptor signaling in teleosts.

Su J Sci China Life Sci. 2025; .

PMID: 39961973 DOI: 10.1007/s11427-024-2822-5.


Exploring molecular targets in cancer: Unveiling the anticancer potential of Paeoniflorin through a comprehensive analysis of diverse signaling pathways and recent advances.

Jan K, Hassan N, James A, Hussain I, Rashid S J Biol Methods. 2024; 11(2):e99010014.

PMID: 39323487 PMC: 11423941. DOI: 10.14440/jbm.2024.0003.


The RNA-binding proteins regulate innate antiviral immune signaling by modulating pattern recognition receptors.

Li J, Yu J, Shen A, Lai S, Liu Z, He T Virol J. 2024; 21(1):225.

PMID: 39304943 PMC: 11414252. DOI: 10.1186/s12985-024-02503-x.


Herpes simplex encephalitis due to a mutation in an E3 ubiquitin ligase.

Bibert S, Quinodoz M, Perriot S, Krebs F, Jan M, Malta R Nat Commun. 2024; 15(1):3969.

PMID: 38730242 PMC: 11087577. DOI: 10.1038/s41467-024-48287-0.


Adaptor molecules mediate negative regulation of macrophage inflammatory pathways: a closer look.

Baig M, Barmpoutsi S, Bharti S, Weigert A, Hirani N, Atre R Front Immunol. 2024; 15:1355012.

PMID: 38482001 PMC: 10933033. DOI: 10.3389/fimmu.2024.1355012.